Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03636152
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT03636152
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03636152. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-14 (actual); primary completion 2024-01-31 (actual). Results posted on 2026-08-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
- Acronym
- MaCK
- Condition
- Chronic Kidney Disease
- Condition
- Cardiovascular Disease
- Condition
- Inflammation
- Condition
- Atherosclerosis
- Condition
- Aortic Stiffness
- Intervention (Procedure)
- MRI carotid
- Intervention (Procedure)
- APWV
- Intervention (Drug)
- Hydroxychloroquine
- Intervention (Drug)
- Matching Placebo
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct03636152- Content hash
3ba921b38c8f081fc84be17895438095ec63f6020fc40606490604cbd1b581e8